ITGAE and neoplasm: In glioblastoma mouse models, elevated sFGL2 was associated with tumour infiltration of immunosuppressive immune cell populations (Tregs, MDSCs, M2 macrophages) and suppressing CD103+ DC differentiation, leading to tumour progression28,30,31.